Recent studies have identified MAGL as a primary regulator of AA and prostaglandin production in mouse brain, and MAGL blockade leads to reduced pro-inflammatory eicosanoids in various neuroinflammatory and neurodegenerative disease models [21–23]. The gene discussed is MGLL; the disease is neurodegenerative disease.